The anti-uPA antibody in the present invention is an antibody that are capable of binding and inhibiting the activity of urokinase plasminogen activator, which is an extracellular serine protease. The specific antibody can inhibit the proteolytic activity of the proteolytically active form of uPA and inhibit activation of single chain uPA from a proteolytically inactive form of uPA to a proteolytically active form of uPA. Thus the antibody can be used for individuals with cancer or inflammatory diseases.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.